Silo Pharma Inc SILO 深 滬
已收盤 05-22 16:00:00 美东时间
0.391
+0.015
+3.99%
華盛通- 最 高0.408
- 今 開0.389
- 成交量 22.55万股
- 最 低 0.3807
- 昨 收 0.376
- 總市值 636.02万
- 52周最高 1.01
- 市盈率 靜 --
- 換手率 1.39%
- 52周最低 0.221
- 委 比 -99.43%
- 總股本 1626.66万
- 歷史最高 7.26
- 量 比 1.24
- 振 幅 7.26%
- 歷史最低 0.221
- 每 手 1
- 風險率 0.14%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多SILO Pharma Q1 EPS $(0.12) Up From $(0.23) YoY, Sales $18.026K, Same YoY
SILO Pharma (NASDAQ:SILO) reported quarterly losses of $(0.12) per share. This is a 47.83 percent increase over losses of $(0.23) per share from the same period last year. The company reported $18.026 thousand in sales
05-15 04:20
Silo Pharma Q1 FY26 net loss widens 59.7% to $1.65 million
Silo Pharma Q1 FY26 net loss widens 59.7% to $1.65 million Silo Pharma posted a wider net loss of USD 1.65 million, versus a 59.7% increase from the year-ago quarter, as operating loss widened 45.7% to USD 1.59 million. Revenue was flat at USD 18,026, while cost of revenues more than doubled to USD
05-14 18:05
Silo Pharma Launches Ibogaine-Based TBI Drug Initiative, Files Patent Amid Growing Psychedelic Therapy Push
New initiative from Silo Pharma designed to align with federal actions to accelerate mental health innovation using psychedelic medicinesSilo Pharma targets unmet need in a drug market with no FDA-approved therapies that
05-07 20:20
Silo Pharma highlights SPC-15 PTSD program after Trump order on psychedelic research
Silo Pharma highlights SPC-15 PTSD program after Trump order on psychedelic research Silo Pharma highlighted its PTSD drug program SPC-15 following President Trump executive order signed April 18, 2026 directing US agencies to accelerate psychedelic-therapy research and patient access. SPC-15 target
04-20 18:45
Silo Pharma Highlights Pipeline Strength Amid Rising U.S. Policy Focus On Psychedelic Mental Health Treatments.
SPC-15 Intranasal PTSD Program Aligns with Federal Push to Fast-Track Novel Mental Health TherapiesSARASOTA, Fla., April 20, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ:SILO), a developmental-stage
04-20 18:37
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Lunai Bioworks (NASDAQ:LNAI) stock moved upwards by 47.2% to $0.41 dur...
04-08 01:05
Levi Strauss, Greenbrier And 3 Stocks To Watch Heading Into Tuesday
U.S. stock futures down, investors should watch Levi Strauss, Silo Pharma, Greenbrier, Mach Natural Resources, and Phoenix Education Partners.
04-07 15:21
Silo Pharma Secures European Patent Office Nod For Columbia‑Licensed Stress Therapy Using Serotonin 4 Receptor Agonists
EPO Greenlights Claims Covering Preventative use of therapy targeting 5-HT4 Pathway and Expands Silo Pharma IP PortfolioSARASOTA, FL, April 06, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ:SILO) ("Silo" or the
04-07 04:19
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Can Fite Biopharma (AMEX:CANF) stock rose 17.6% to $5.88 during Wednes...
03-04 20:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Vir Biotechnology (NASDAQ:VIR) shares moved upwards by 65.0% to $12.26...
02-24 20:05
